The Nasdaq indicated that there was a record amount of biotech initial public offerings (IPOs) in 2018, totaling around $8.2 billion raised, breaking 2014’s record of $6.5 billion.
Celltrion Inc. signed an ‘Incubation’ agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis.
AstraZeneca has invested another $140 million in Moderna Therapeutics’ drugs based on a molecule known as messenger RNA.
(Reuters Health) – Adults who get too much or too little sleep may have the beginnings of “hardening” of the arteries, which can be an early sign of heart disease, according to a new study. “Many people, up to one third or one fourth of the general population, suffer from inadequate sleep – either insufficient […]
Between 1999 and 2012, the use of cholesterol-lowering statin drugs increased among people over age 79 with no history of coronary heart disease, stroke or vascular disease, according to a new study. People who have had a heart attack, stroke or diabetes are often prescribed a statin like atorvastatin (Lipitor) to reduce their risk of […]